Yu Jia, Xu Gezhi, Chang Qing, Ye Xiaofeng, Li Lei, Jiang Chunhui, Zhao Qi
Department of Ophthalmology, Eye & Ear Nose Throat Hospital of Fudan University, Shanghai 200031, China.
Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University, Shanghai 200031, China.
J Ophthalmol. 2019 Aug 14;2019:5970659. doi: 10.1155/2019/5970659. eCollection 2019.
To investigate the risk factors for persistent or recurrent central serous chorioretinopathy (CSC).
Consecutive treatment-naïve CSC patients were included from January 2017 to October 2018. All patients were asked to complete questionnaires, addressing previously described risk factors for the development of CSC. Patients were divided into two groups: those with acute CSC, who were in the first episode, with spontaneous resolution of subretinal fluid within 3 months, and with no recurrence within 1 year; and those with persistent or recurrent CSC, the remaining patients.
In total, 138 patients were enrolled: 20 (14.5%) with acute CSC and 118 (85.5%) with persistent or recurrent CSC. Using multivariate analysis, male sex (odds ratio (OR), 95% confidence interval: 5.63 [1.02-31.02]; =0.047), older age (OR: 1.14 [1.03-1.25]; =0.008), and higher Insomnia Severity Index score (OR: 1.30 [1.05-1.60]; =0.015) were found to be independently associated with persistent or recurrent CSC.
Male sex, age, and sleep disorders are risk factors for persistent or recurrent CSC in the natural history. These patients may require early photodynamic therapy. Treatment for sleep disorders is strongly recommended. All CSC patients may require careful and periodic follow-up.
探讨持续性或复发性中心性浆液性脉络膜视网膜病变(CSC)的危险因素。
纳入2017年1月至2018年10月连续未经治疗的CSC患者。所有患者均被要求完成问卷,问卷涉及先前描述的CSC发生的危险因素。患者被分为两组:急性CSC组,即首次发病,视网膜下液在3个月内自发消退且1年内无复发的患者;持续性或复发性CSC组,即其余患者。
共纳入138例患者:20例(14.5%)为急性CSC,118例(85.5%)为持续性或复发性CSC。采用多因素分析,发现男性(比值比(OR),95%置信区间:5.63[1.02 - 31.02];P = 0.047)、年龄较大(OR:1.14[1.03 - 1.25];P = 0.008)以及失眠严重程度指数得分较高(OR:1.30[1.05 - 1.60];P = 0.015)与持续性或复发性CSC独立相关。
男性、年龄和睡眠障碍是自然病程中持续性或复发性CSC的危险因素。这些患者可能需要早期光动力治疗。强烈建议对睡眠障碍进行治疗。所有CSC患者可能都需要仔细且定期的随访。